USA 1-800-227-2862 (BBRAUN2)
Home > Press > Company News

Company News


Read news and press releases about B. Braun Medical Inc. (B.Braun), covering subjects ranging from products, related events, company news and more.


B. Braun Receives FDA Approval for Nutrilipid® 20%

An Intravenous Fat Emulsion Approved for Adult and Pediatric Patients

BETHLEHEM, PA – August 13, 2014 – B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, announced today that it has received U.S. Food and Drug Administration (FDA) approval of Nutrilipid® 20% (I.V. fat emulsion) for parenteral nutrition therapy in adult & pediatric patients. Nutrilipid 20% is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated. The approval of Nutrilipid 20% will help alleviate the short supply of lipid emulsion products the U.S. has seen over the past two years. It will be available in flexible containers that are not made with DEHP, PVC or natural rubber latex. Launch plans are expected soon.

“We are very pleased that the FDA has granted approval for Nutrilipid 20%,” said Rick Williamson, Vice President of Pharmaceutical Marketing at B.Braun. “Through our state-of-the-art production facility, we are committed to providing quality clinical nutrition products so that patients have access to parenteral nutrition they often critically need. B.Braun continues to expand upon its customized approach to clinical nutrition and compounding to meet the needs of patients along the entire clinical pathway," added Williamson.

About B. Braun
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its “Sharing Expertise®” philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, B.Braun Interventional Systems, Aesculap® and CAPS®. B.Braun’s U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 50,000 employees in more than 60 countries throughout the world. To learn more about B.Braun visit